Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease
Condition: Primary Disease Intervention: Drug: VPRIV Sponsor: Shaare Zedek Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2018 Category: Research Source Type: clinical trials
